Condition : Rheumatoid Arthritis Intervention : Drug: etanercept Sponsor : Pfizer Recruiting - verified August 2011

Condition : Osteoarthritis of the Knee Interventions : Drug: 3%-Diclofenac-Nano-Emulsion Cream; Drug: Placebo cream Sponsor : Pharmos Completed - verified August 2011

Condition : Osteoarthritis of the Knee Interventions : Drug: 3%-Diclofenac-Nano-Emulsion Cream; Drug: Placebo cream Sponsor : Pharmos Completed - verified August 2011

Conditions : Hip Osteoarthritis; Knee Osteoarthritis Interventions : Procedure: X-rays; Biological: biological samples; Other: medical information about osteoarthritis Sponsor : Central Hospital, Nanc...

Condition : Advanced Glenohumeral Arthritis Intervention : Device: Humeral surface replacement hemiarthroplasty (CAP) Sponsors : University of Calgary; DePuy International; Johnson & Johnson Active, n...

Condition : Advanced Glenohumeral Arthritis Intervention : Device: Humeral surface replacement hemiarthroplasty (CAP) Sponsors : University of Calgary; DePuy International; Johnson & Johnson Active, n...

Condition : Rheumatoid Arthritis Interventions : Drug: rituximab [MabThera/Rituxan]; Drug: Methotrexate Sponsors : Hoffmann-La Roche; Hoffmann-La Roche Completed - verified September 2013

The purpose of this study is to examine the effects of etanercept (10 mg and 25 mg) compared with methotrexate (up to 8 mg per week) on the slowing of joint destruction.

Condition : Rheumatoid Arthritis Intervention : Sponsors : Genentech; Genentech; Biogen Idec Active, not recruiting - verified September 2013

D-blind, placebo-controlled, parallel-arm, multicentre, prospective dose-finding trial of the safety and efficacy of atacicept in subjects with active rheumatoid arthritis who have failed a three mont...